image
Verastem, Inc. VSTM
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 6.525
-6.85 %
$ 336 M
Market Cap
-1.78
P/E
BALANCE SHEET
102 M ASSETS
-32.18%
Growth Rates
1Year -32.18%
3Years -2.23%
5Years -6.88%
7Years 1.77%
10Years 0.29%
130 M LIABILITIES
41.24%
Growth Rates
1Year 41.24%
3Years 83.52%
5Years -1.10%
7Years 22.17%
10Years 29.43%
-28.9 M EQUITY
-50.36%
Growth Rates
1Year -50.36%
3Years -9.97%
5Years -38.12%
7Years -5.97%
10Years -2.86%
BALANCE SHEET DECOMPOSITION
Balance Sheet Verastem, Inc.
image
Current Assets 95 M
Cash & Short-Term Investments 88.8 M
Receivables 200 K
Other Current Assets 5.94 M
Non-Current Assets 6.58 M
Long-Term Investments 0
PP&E 1.44 M
Other Non-Current Assets 5.14 M
87.47 %5.85 %5.06 %Total Assets$101.5m
Current Liabilities 31 M
Accounts Payable 4.03 M
Short-Term Debt 995 K
Other Current Liabilities 26 M
Non-Current Liabilities 99.5 M
Long-Term Debt 40.7 M
Other Non-Current Liabilities 58.7 M
3.09 %19.90 %31.22 %45.03 %Total Liabilities$130.4m

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011
ASSETS
Cash & Cash Equivalents 88.8 78.8 74.9 100.3 67.8 43.5 129.9 82.2 32.3 110.3 33.9 18.9 10.1 21.0
Short Term Investments 0 59.2 13.0 79.0 73.4 32.0 119.8 4.5 48.5 85.4 58.8 82.4 46.5 26.9
Receivables 0.2 0 31 K 0.5 0.2 2.5 0.3 0 0.2 0.2 2.3 0.1 0.2 0
Inventory 0 0 0 (100.8) 0 3.1 0.3 0 0 (0.2) 0 0 0 0
Other Current Assets 5.9 6.6 4.9 5.0 6.9 7.7 3.0 1.1 0.2 0.4 0.2 0.5 0.3 0.2
Total Current Assets 95.0 143.7 92.9 105.7 144.9 85.0 253.3 87.8 81.3 110.8 95.3 102.0 57.1 47.9
PP&E 1.4 1.2 1.9 0.2 3.1 4.0 1.4 0.9 1.4 2.0 2.8 0.6 0.8 0.7
Intangible Assets 0 0 0 0 0 20.0 21.6 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0.2 0.2 0.2 6.0 35.0 0 0 0 0 0 22.3 34.9 9.0
Other Long Term Assets 5.1 4.6 58 K 2.5 0.3 36.1 1.0 1.1 0.9 0.2 0.5 0.3 86 K 1.4
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 101.5 149.7 95.0 108.7 154.3 145.0 277.2 89.8 83.6 113.1 98.6 125.3 92.9 59.0
LIABILITIES
Accounts Payable 4.0 7.2 4.9 2.3 1.9 9.7 10.3 9.2 4.1 3.9 3.2 2.8 1.8 2.3
Short Term Debt 1.0 1.9 1.1 1.3 1.1 0.8 5.7 0 0 0 0 0 0 0
Other Current Liabilities 26.0 17.0 15.0 15.0 14.1 19.4 21.1 7.9 6.9 6.2 6.0 5.0 0.6 0.9
Total Current Liabilities 31.0 26.4 21.7 18.6 17.1 29.9 37.1 17.1 11.0 10.0 9.2 7.8 2.4 3.1
Long Term Debt 40.7 40.6 26.0 2.5 22.0 107.1 114.7 14.8 0 0 0 0 0 0
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities 58.7 4.2 0 0 0 0.9 1.1 0.2 0.3 0.5 0.7 11 K 58 K 68.6
Total Liabilities 130.4 92.3 47.7 21.1 39.1 137.9 152.9 32.1 11.3 10.6 9.9 7.8 2.5 71.8
EQUITY
Common Stock 4 K 3 K 20 K 19 K 17 K 8 K 7 K 5 K 4 K 4 K 3 K 3 K 2 K 1 K
Retained Earnings (955.5) (824.9) (737.5) (663.7) (592.5) (524.8) (375.6) (303.1) (235.3) (198.9) (141.0) (87.7) (46.5) (14.5)
Other Accumulative Comprehensive Income/Loss 0 13 K 0 34 K 53 K 14 K 0.1 2 K 29 K 43 K 11 K 28 K 22 K (14.5)
Total Equity (28.9) 57.4 47.4 87.6 115.3 7.2 124.3 57.7 72.3 102.5 88.8 117.4 90.5 (12.8)
Total Liabilities and Equity 101.5 149.7 95.0 108.7 154.3 145.0 277.2 89.8 83.6 113.1 98.6 125.3 92.9 59.0
SHARES OUTSTANDING
Common Shares Outstanding 35.7 22.1 16.1 14.5 12.8 6.2 5.8 3.2 3.1 3.0 2.2 1.9 1.6 1.7 1.5